Correction to: Oncogene https://doi.org/10.1038/onc.2016.131, published online 02 May 2016
Following publication of this article, an error was noted in the presentation of panels in Figure 3f, which illustrates the effect of a CCR2 inhibitor, RS504393, on blood CD11b+Ly6Chigh cells in mice inoculated with B16-F0 cells and TE-MSCs.
Specifically, in the bottom right panel the authors inadvertently used flow cytometry data from the B16-F0 + CCR2 inhibitor condition instead of the correct B16-F0 + TE-MSCs + CCR2 inhibitor data. The corrected figure is provided below.
The authors apologize for this error and any inconvenience it may have caused.
Corrected
Published
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Lin, L.Y., Du, L.M., Cao, K. et al. Correction: Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities. Oncogene 45, 663 (2026). https://doi.org/10.1038/s41388-026-03678-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41388-026-03678-z
